May 22, 2020
Luminex Corporation Declares Second Quarter Cash Dividend
May 04, 2020
Luminex Corporation Reports First Quarter 2020 Results
Apr 22, 2020
Luminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020
Apr 06, 2020
Luminex Corporation Pre-Release of 1st Quarter Revenue
Mar 31, 2020
Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
Mar 13, 2020
Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts
Feb 24, 2020
Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance
Feb 18, 2020
Luminex Corporation Declares First Quarter Cash Dividend
Feb 13, 2020
Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020
Jan 23, 2020
Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020
Jan 12, 2020
Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference
Dec 06, 2019
Luminex Corporation Declares Fourth Quarter Cash Dividend
Nov 25, 2019
Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019
Nov 04, 2019
Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
Oct 25, 2019
Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019
Oct 01, 2019
Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay
Sep 26, 2019
Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019
Jul 11, 2019
Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019
Jul 01, 2019
Luminex Submits ARIES MRSA Assay for FDA Clearance
May 28, 2019
EDP Biotech to Develop and Market Colorectal Cancer Early Detection Blood Test Using Luminex xMAP® Technology